Austria - Renin-Angiotensin System Medicine Use
Since 2014, Austria Renin-Angiotensin System Medicine Use was up 10.2% year on year. In 2019, the country was ranked number 20 among other countries in Renin-Angiotensin System Medicine Use at 143.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Austria is overtaken by Netherlands, which was number 19 at 147.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Iceland with 135.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 0.6% versus 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria witnessed the best average annual growth at +10.2% per year, while Chile witnessed the worst performance at -3.5% per year.
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 143.80 |
2018 | 142.60 |
2017 | 144.00 |
2016 | 85.80 |
2015 | 87.00 |
How does Austria rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
19 |
#19
Netherlands
|
147 | 2019 | +2.1 % | +0.4 % | View data | |
20 |
#20
Austria
|
144 | 2019 | +0.8 % | +10.2 % | View data | |
21 |
#21
Iceland
|
135 | 2019 | +0.1 % | +2.1 % | View data |